Status:
UNKNOWN
Rehabilitation in Patients With Human Lymphotropic Virus Type I
Lead Sponsor:
Universidade Metodista de Piracicaba
Collaborating Sponsors:
Universidade do Estado do Pará
Conditions:
Human T-Lymphotropic Virus Type 1 Associated Myelopathy
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
In our times, it is known that approximately 5% of patients seropositive for HTLV-1 may desengage a frame with several neurological disorders, which is called myelopathy associated with HTLV-1, charac...
Eligibility Criteria
Inclusion
- Seropositive carriers for HTLV-1 with PET
Exclusion
- lung diseases
- heart disease
- arterial hypertension
- cognitive impairments
Key Trial Info
Start Date :
April 27 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04875403
Start Date
April 27 2021
End Date
December 30 2022
Last Update
May 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidade do Estado do Pará
Belém, Pará, Brazil, 66055-490